RxDoctor Payments Data

Ching-Wei Tzeng, MD

Surgical Oncology · Houston, TXNPI 1164636908

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.6%), consulting fees and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Johnson & Johnson at 39.3% of the total.

$5,670in general payments, 2019–2025

Across 41 payments — averaging $138.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Intuitive Surgical$1K
  • Medtronic$831
  • Integra Lifesciences Corporation$614
  • Dilon Technologies, Inc.$475
  • Intera Oncology, Inc$156
  • plus $361 from 4 others
$108,000in research payments, 2019–2025

Across 4 payments — averaging $27,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sirtex Medical Inc$108K

What the payments were for

  • Consulting fees$1,51527%
  • Food & beverage$3,32159%
  • Education$81314%
  • Entertainment$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson7$2,229
Intuitive Surgical6$1,003
Medtronic12$831
Integra Lifesciences Corporation6$614
Dilon Technologies, Inc.3$475
Intera Oncology, Inc1$156
Jazz Pharmaceuticals Inc.1$128
Medical Device Business Services, Inc.3$125
Angiodynamics, Inc.1$87
Hitachi Healthcare Americas Corp.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,670 in reported general payments places this provider in the 75th percentile of 191 surgical oncology providers in Texas.

See all surgical oncology providers in Texas

Medicare billing

Part B allowed, 2024
$98,631
Medicare patients
126
Services billed
311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →